1. Home
  2. LODE vs ORGO Comparison

LODE vs ORGO Comparison

Compare LODE & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comstock Inc.

LODE

Comstock Inc.

BUY

Current Price

$1.78

Market Cap

161.9M

Sector

Industrials

ML Signal

BUY

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

BUY

Current Price

$1.04

Market Cap

127.6M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
LODE
ORGO
Founded
1999
1985
Country
United States
United States
Employees
N/A
854
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.9M
127.6M
IPO Year
2004
2016

Fundamental Metrics

Financial Performance
Metric
LODE
ORGO
Price
$1.78
$1.04
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
★ $2.00
AVG Volume (30 Days)
★ 1.5M
750.4K
Earning Date
11-02-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
63.55
★ 1600.00
EPS
★ N/A
N/A
Revenue
$1,553,796.00
★ $564,169,000.00
Revenue This Year
$303.79
N/A
Revenue Next Year
$410.04
$37.55
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 17.04
52 Week Low
$1.70
$0.93
52 Week High
$4.98
$7.08

Technical Indicators

Market Signals
Indicator
LODE
ORGO
Relative Strength Index (RSI) 23.75 26.19
Support Level N/A N/A
Resistance Level $3.32 $2.57
Average True Range (ATR) 0.11 0.08
MACD -0.01 -0.01
Stochastic Oscillator 11.29 22.22

Price Performance

Historical Comparison
LODE
ORGO

About LODE Comstock Inc.

Comstock Inc commercializes technologies that convert underutilized waste and natural resources into clean energy and supporting products, including electrification, metals, and minerals from end-of-life solar panels. Its subsidiary focuses on producing renewable fuels from waste, energy crops, and woody biomass, supported by facilities in Wisconsin, pilot farms, a biorefinery site in Tulsa, and solar panel recycling operations in Nevada. The Company operates through two high-growth segments and a corporate segment, with its activities grouped into Metals, which generates the majority of revenue, Fuels, Mining, Strategic Investments, and Corporate Services.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: